Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 +0.04 (+3.24%)
As of: Aug 21, 2026 · 1:39 PM EDT

Enveric Biosciences (ENVB) EBIT Margin Growth (5y) (2019 - 2020)

Enveric Biosciences (ENVB) EBIT Margin Growth (5y) (2019 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.40 Bn 131.54 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.13 Bn 78.13 Bn 3.93 Bn
3 Argenx Se 65.58 Bn 60.40 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 BeOne Medicines 42.18 Bn 37.08 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.97 Bn 9.58 Bn 668.28 Mn
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Enveric Biosciences 5.72 Mn -2.57 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 130.00
Jun 30, 2020 -1,388.00
Mar 31, 2020 -3,384.00
Jun 30, 2019 -2,781.00